India & Ernst & Young
10 shared events · Importance 4 · Last updated Jul 31, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
India: The report highlights India's growing wealth and family office ecosystem, which could attract more foreign investment and boost the country's capital markets and economic growth.
Ernst & Young: Co-authored the report, showcasing its expertise in family office advisory. The report's findings could lead to increased demand for its advisory services in India.
Aug 20, 2026 · 6 articles
Business
India: India is the focal market; fundraising doubled to $21.2 billion while investments fell 36%, reflecting strong long-term confidence despite near-term caution.
Ernst & Young: Ernst & Young co-authored the report and provided expert commentary, reinforcing its role as a key advisor in the PE/VC space.
Jul 31, 2026 · 6 articles
Business
India: The merger supports India's energy transition and infrastructure growth by creating a larger financing institution capable of meeting the power sector's growing financial requirements and implementing government reforms.
Ernst & Young: Ernst & Young Merchant Banking Services LLP prepared a joint valuation report for the merger, contributing to the share exchange ratio determination.
Jun 28, 2026 · 6 articles
Regulatory
India: India amended its trade policy to ban forced labour imports, addressing US concerns and aligning with international standards.
Ernst & Young: EY India commented on India's alignment with ILO standards.
Jul 14, 2026 · 21 articles
International
India: India secured a lower 10% tariff after amending its foreign trade policy to ban forced labor imports, a diplomatic win.
Ernst & Young: Ernst & Young trade expert Blake Harden noted that much uncertainty remains and more tariffs are likely.
Apr 20, 2026 · 318 articles
Business
India: PolyPeptide has manufacturing facilities in India; Samsung Biologics — Samsung Biologics America gains foothold.
Ernst & Young: Accounting and tax adviser to Samsung Biologics — Samsung Biologics America.
Jul 19, 2026 · 22 articles
Business
India: India is mentioned as a country where AGI has manufacturing facilities. The event does not directly affect India.
Ernst & Young: Ernst & Young is mentioned as the firm where Haaris Uddin began his career as an auditor. The event does not directly affect EY.
Jul 06, 2026 · 7 articles
Regulatory
Ernst & Young: Ernst & Young executives are accused by India — Securities and Exchange Board of India of breaching insider trading rules and having weak compliance processes related to the Yes Bank share sale. The firm failed to place Yes Bank on a sufficiently broad 'restricted list'.
Jan 23, 2026 · 8 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how India and Ernst & Young interact across events, view sentiment trends, and discover connected entities.
Open Dashboard